|Title:||Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones|
|Abstract:||2-(3-[4-(3-Halophenyl)-1-piperazinyl]propyl derivatives of certain 4-alkyl- or 4-phenoxyalkyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and triazol-3,5-diones are psychotropic agents having promise as antidepressants by virtue of their receptor site binding affinity profiles and animal pharmacology.|
|Inventor(s):||Mayol; Robert F. (Durham, CT), Luke; George M. (LaFayette, NY)|
|Assignee:||Bristol-Myers Squibb Company (New York, NY)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Dosage form;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.